8th Annual OPT Congress – Oligonucleotide & Precision Therapeutics
From the 13th to the 14th of March 2023 our CEO Dr. Thomas Frischmuth will take part in the 8th Annual OPT Congress – Oligonucleotide & Precision Therapeutics in Boston (US).
The conference is dedicated to the discovery, development and delivery of oligonucleotide and peptide therapeutics.
